Investigating Secreted Proteins as Novel Therapeutic Targets for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rapidly rising in global prevalence and now stands as a leading cause of ...
